| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040052787 Screening for menstruation disorders; measurement nucleic acids or protein |
| 03/18/2004 | US20040052785 Synergistic mixtures; antitumor agents |
| 03/18/2004 | US20040052739 Sunscreen agents; radiation resistance |
| 03/18/2004 | US20040052732 Synergistic mixture of antiserotonine agents and glucocorticoids; inhalation |
| 03/18/2004 | DE10241407A1 Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe Treatment not allergic rhinitis by selective phosphodiesterase 4 inhibitors |
| 03/18/2004 | DE10240735A1 Regulating human endostatin expression, e.g. for treating CNS disorders or tumors, using nitrogen monoxide signal cascade modulators |
| 03/18/2004 | CA2499380A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | CA2497989A1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2497955A1 Medicament for preventing and/or treating inflammatory bowel disease |
| 03/18/2004 | CA2497902A1 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 03/18/2004 | CA2497901A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | CA2497873A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | CA2497464A1 A therapeutic agent for improving hypogastric and/or perineal pains |
| 03/18/2004 | CA2497374A1 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | CA2493974A1 Pharmaceutical dosage form comprising a sulfite compound |
| 03/17/2004 | EP1398313A1 Novel heterocyclic derivatives and medicinal use thereof |
| 03/17/2004 | EP1398036A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/17/2004 | EP1398030A2 Dipeptidyl peptidase IV effectors |
| 03/17/2004 | EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy |
| 03/17/2004 | EP1397681A1 Method for identification of agents for the treatment of diabetes |
| 03/17/2004 | EP1397507A1 Methods and compositions for treating cardiovascular disease using 10218 |
| 03/17/2004 | EP1397484A2 Methods and products related to fgf dimerization |
| 03/17/2004 | EP1397429A1 Composite particles, derived conjugates, preparation method thereof and applications of same |
| 03/17/2004 | EP1397386A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 03/17/2004 | EP1397380A2 Multiple antigenic peptide displaying multiple copies of an epitope of a plaque-forming polypeptide and methods of using same |
| 03/17/2004 | EP1397374A2 Siglec inhibitors |
| 03/17/2004 | EP1397369A1 New use or cyclolignans and new cyclolignans |
| 03/17/2004 | EP1397365A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 03/17/2004 | EP1397364A1 Novel pyrrole derivatives as pharmaceutical agents |
| 03/17/2004 | EP1397363A1 5-ethyl-imidazotriazinones |
| 03/17/2004 | EP1397361A1 Carboline derivatives as pdev inhibitors |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1397359A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 03/17/2004 | EP1397356A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1397354A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 03/17/2004 | EP1397351A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/17/2004 | EP1397350A1 Isoquinolinone derivatives as parp inhibitors |
| 03/17/2004 | EP1397348A2 Factor xa inhibitor |
| 03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/17/2004 | EP1397172A1 Safety shield system for prefilled syringes |
| 03/17/2004 | EP1397170A1 Safety shield system for prefilled syringes |
| 03/17/2004 | EP1397158A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS |
| 03/17/2004 | EP1397156A2 Oral administration of parathyroid hormone and calcitonin |
| 03/17/2004 | EP1397153A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 03/17/2004 | EP1397151A2 Wnv core protein/capsid interacting protein and uses of the same |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397145A2 Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP1397138A2 Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| 03/17/2004 | EP1397135A2 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways |
| 03/17/2004 | EP1397132A1 Pirenzepine ophthalmic gel |
| 03/17/2004 | EP1397130A1 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 03/17/2004 | EP1397129A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors |
| 03/17/2004 | EP1397105A1 Methods for inhibiting angiogenesis |
| 03/17/2004 | EP1246816B1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1242105B1 Combination of ginseng and ginkgo to improve cognitive skills |
| 03/17/2004 | EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 03/17/2004 | EP1188760B1 Ip3 receptor ligands |
| 03/17/2004 | EP1176871A4 Novel beta-secretase and modulation of beta-secretase activity |
| 03/17/2004 | EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 03/17/2004 | EP1144413B1 2,5-diazabicyclo 2.2.1]heptane derivatives, their preparation and therapeutic uses |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | EP1140820B1 New amidino derivatives and their use as thrombin inhibitors |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP1137497B1 Apparatus for separating particles of cohesive material according to size and process |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1071684B1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 03/17/2004 | EP1030686B1 Lyophilizate of lipid complex of water insoluble porphyrins |
| 03/17/2004 | EP0975775B1 Regulatory system for inducible expression of genes with lambdoid promoters |
| 03/17/2004 | EP0971588B1 Novel cannabinoid receptor modulators |
| 03/17/2004 | EP0891362B1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | EP0655917B1 Crystalline amifostine compositions and methods for the preparation and use of same |
| 03/17/2004 | CN1483079A Immunoregulation polynucleotide and using method thereof |
| 03/17/2004 | CN1483035A Sulfamidothienopyrimidines |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1483033A Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 03/17/2004 | CN1483029A Sodium channel modulators derived from 2-piperidylimidazoles |
| 03/17/2004 | CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1483022A Crystalline forms of atorvastatin |
| 03/17/2004 | CN1483021A Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 03/17/2004 | CN1482918A Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 03/17/2004 | CN1482917A New therapeutic uses of smr1 peptides |
| 03/17/2004 | CN1482909A Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 03/17/2004 | CN1482906A New clinical treatment |
| 03/17/2004 | CN1482902A Inhibitor for the production of tnf alpha |
| 03/17/2004 | CN1482897A Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid |
| 03/17/2004 | CN1481851A Process of oil for dispelling wind |
| 03/17/2004 | CN1481849A Oil essence for relieving fatigue and preserving health |
| 03/17/2004 | CN1481848A Anti-age capsule |
| 03/17/2004 | CN1481847A Anti-age dan formulation |